BD to Present at Barclays 28th Annual Global Healthcare Conference
Get Alerts BDX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: -13.4%
Join SI Premium – FREE
FRANKLIN LAKES, N.J.,
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media | Investors: |
| SVP, Investor Relations |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-barclays-28th-annual-global-healthcare-conference-302694898.html
SOURCE BD (Becton, Dickinson and Company)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boo Bash Fall Festival to Make California Debut September 18, Bringing 100,000+ Square-Foot Immersive Pumpkin Patch to Escondido
- abrdn Global Infrastructure Income Fund (ASGI) Announces Transferable Rights Offering Terms
- Furnished Quarters Named Best Corporate Housing Provider in Brooklyn
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share